Heteroaryl‐Substituted 4‐(1H‐pyrazol‐1‐yl)‐5,6‐dihydro‐1H‐pyrrolo[2,3‐d]pyrimidine Derivatives as Potent and Selective Corticotropin‐Releasing Factor Receptor‐1 Antagonists

No abstract is available for this paper.

• Publication year

  2008

• Venue

  ChemMedChem

• Publication date

  2008-02-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/cmdc.200700230PMID 18000940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclopenta[d]pyrimidines and Dihydropyrrolo[2,3‐d]pyrimidines as Potent and Selective Corticotropin‐Releasing Factor 1 Receptor Antagonists

  2007cited by this paper
• Drs. DeVane and Pollock Reply

  2000cited by this paper
• Pharmacologic characteristics of ideal antidepressants in the 21st century.

  2000cited by this paper
• Managing the agitated psychotic patient: a reappraisal of the evidence.

  2000cited by this paper
• Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents.

  2000cited by this paper
• Haloacetylated enol ethers. 9. Synthesis of 4-trifluoromethyl-2-methyl[phenyl]pyrimidines and tetrahydro derivatives

  1998cited by this paper
• Subthreshold syndromes of depression and anxiety in the community.

  1997cited by this paper
• Efficacy issues with antidepressants.

  1997cited by this paper
• Dose-related thrombocytopenia and macrocytic anemia associated with valproate use in bipolar disorder.

  1997cited by this paper
• The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies.

  1993cited by this paper
• Ciba Foundation Symposium 172 - Corticotropin-Releasing Factor

  1993cited by this paper
• [Corticotropin releasing factor].

  1985cited by this paper
• Distress vocalization in rat pups. A simple screening method for anxiolytic drugs.

  1985cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

  1981cited by this paper

• Pyrazolyldiazonium Salts in the Synthesis of 4‐Amino‐1,3’‐bipyrazoles

  2023cites this paper
• Bicyclic 5-6 Systems—Three Heteroatoms 1:2

  2021cites this paper
• Design, Synthesis, Structural Optimization, SAR, in silico Prediction of Physicochemical Properties and Pharmacological Evaluation of Novel & Potent Thiazolo[4,5-d]pyrimidine Corticotropin Releasing Factor (CRF) Receptor Antagonists.

  2021cites this paper
• Synthesis of 2-imino and 2-hydrazono thiazolo[4,5-d]pyrimidines as corticotropin releasing factor (CRF) antagonists.

  2017cites this paper
• Structure and Function of Small Non-Peptide CRF Antagonists and their Potential Clinical Use.

  2017cites this paper
• Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF₁) receptor antagonists.

  2011cites this paper
• CRF 1 antagonists in animal models of anxiety , depression and addictive disorders

  2010cites this paper
• Progress in corticotropin-releasing factor-1 antagonist development.

  2010cites this paper
• Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studies.

  2008cites this paper